Moteur de recherche d’entreprises européennes

Financement britannique (214 360 £) : Fabrication d’amines chirales à l’aide de méthodes de traitement catalytique et de traitement par flux Ukri 01/02/2013 Recherche et innovation du Royaume-Uni, Royaume Uni

Vue d’ensemble

Texte

Fabrication d’amines chirales à l’aide de méthodes de traitement catalytique et de traitement par flux

Abstract Chiral amines are important building blocks used in 40% pharmaceutical products, 20% of crop protection compounds and are high value chemical intermediates. Current synthetic methods use wasteful resolution processes. This project will improve manufacturing efficiency by developing catalytic (transfer) hydrogenation methods to make specific types of chiral amines. The project aims to develop and exploit new catalysts, to develop solid supported variants of these, and use them in novel flow reactors. This allows reduced effective loadings of the metal catalysts, efficient metal recovery and switch from batch to continuous processing. The project generates new asymmetric catalysts, opens new market opportunities for flow reactors, and fulfils high demand for chiral amines required by end user companies made using more efficient processes to lower cost, reduce waste, improve quality and availability.
Category Collaborative R&D
Reference 101328
Status Closed
Funded period start 01/02/2013
Funded period end 31/01/2015
Funded value £214 360,00
Source https://gtr.ukri.org/projects?ref=101328

Participating Organisations

YPROTECH LIMITED

£62 500,00

AM TECHNOLOGY LIMITED

£110 000,00

SYNGENTA LIMITED

£9 796,00

THE RUSSELL GROUP OF UNIVERSITIES
PFIZER LIMITED

£11 000,00

ASTRAZENECA PLC

£11 000,00

UNIVERSITY OF LEEDS
CHIROTECH TECHNOLOGY LIMITED

£10 064,00

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Apex Molecular Ltd., Manchester, Royaume Uni.